The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Immense Essence of Excellence: Marine Microbial Bioactive Compounds
Open accessAbstract
Oceans have borne most of the biological activities on our planet. A number of biologically active compounds with varying degrees of action, such as anti-tumor, anti-cancer, anti-microtubule, anti-proliferative, cytotoxic, photo protective, as well as antibiotic and antifouling properties, have been isolated to date from marine sources. The marine environment also represents a largely unexplored source for isolation of new microbes (bacteria, fungi, actinomycetes, microalgae-cyanobacteria and diatoms) that are potent producers of bioactive secondary metabolites. Extensive research has been done to unveil the bioactive potential of marine microbes (free living and symbiotic) and the results are amazingly diverse and productive. Some of these bioactive secondary metabolites of microbial origin with strong antibacterial and antifungal activities are being intensely used as antibiotics and may be effective against infectious diseases such as HIV, conditions of multiple bacterial infections (penicillin, cephalosporines, streptomycin, and vancomycin) or neuropsychiatric sequelae. Research is also being conducted on the general aspects of biophysical and biochemical properties, chemical structures and biotechnological applications of the bioactive substances derived from marine microorganisms, and their potential use as cosmeceuticals and nutraceuticals. This review is an attempt to consolidate the latest studies and critical research in this field, and to showcase the immense competence of marine microbial flora as bioactive metabolite producers. In addition, the present review addresses some effective and novel approaches of procuring marine microbial compounds utilizing the latest screening strategies of drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Salinosporamide A, a novel long-lasting proteasome inhibitor isolated from a marine bacterium Salinispora tropica [230] in phase I clinical trials, has more efficacy against a wider range of hematologic malignancies and many solid tumor models, and less cytotoxicity to normal cells (Figure 8) [101].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [101]
The cited source says what the claim attributes to it.
In the citing paper
“Salinosporamide A, a novel long-lasting proteasome inhibitor isolated from a marine bacterium Salinispora tropica [230] in phase I clinical trials, has more efficacy against a wider range of hematologic malignancies and many solid tumor models, and less cytotoxicity to normal cells (Figure 8) [101].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [101]
The cited source says what the claim attributes to it.
In the citing paper
“Tasidotin, Synthadotin (ILX-651), derived from a marine bacterium in phase II clinical trials, and Soblidotin (TZT 1027), the bacterial peptide of marine origin in phase III clinical trials, are promising anticancer agents [101].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [101]
The cited source says what the claim attributes to it.
In the citing paper
“Tasidotin, Synthadotin (ILX-651), derived from a marine bacterium in phase II clinical trials, and Soblidotin (TZT 1027), the bacterial peptide of marine origin in phase III clinical trials, are promising anticancer agents [101].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [101]
The cited source says what the claim attributes to it.
In the citing paper
“Tasidotin, Synthadotin (ILX-651), derived from a marine bacterium in phase II clinical trials, and Soblidotin (TZT 1027), the bacterial peptide of marine origin in phase III clinical trials, are promising anticancer agents [101].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [101]
The cited source says what the claim attributes to it.
In the citing paper
“Salinosporamide A, a novel long-lasting proteasome inhibitor isolated from a marine bacterium Salinispora tropica [230] in phase I clinical trials, has more efficacy against a wider range of hematologic malignancies and many solid tumor models, and less cytotoxicity to normal cells (Figure 8) [101].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Biomedical Compounds from Marine organisms
Jha, R. K., & Zi-rong, X. (2004) · Marine Drugs · doi:10.3390/md203123 · Cited by 324
RetractedFaulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,880
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170
Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057
Marine cyanobacteria—a prolific source of natural products
Burja, A. M., Banaigs, B., Abou-Mansour, E., Grant Burgess, J., & Wright, P. C. (2001) · Tetrahedron · doi:10.1016/s0040-4020(01)00931-0 · Cited by 841
Inagaki, F., Nunoura, T., Nakagawa, S., Teske, A., Lever, M. A., Lauer, A., Suzuki, M., Takai, K., Delwiche, M. E., Colwell, F. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511033103 · Cited by 694
The odyssey of marine pharmaceuticals: a current pipeline perspective
Mayer, A. M. S., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kem, W. R., Little, R. D., McIntosh, J. M., Newman, D. J., Potts, B. C. M., & Shuster, D. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.005 · Cited by 669
Bioactive compounds from cyanobacteria and microalgae: an overview
Singh, S., Kate, B. N., & Banerjee, U. C. (2005) · Critical Reviews in Biotechnology · doi:10.1080/07388550500248498 · Cited by 619
Bioactive natural products from marine cyanobacteria for drug discovery
Tan, L. T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.01.012 · Cited by 534
Biosurfactants, bioemulsifiers and exopolysaccharides from marine microorganisms
Satpute, S., Banat, I. M., Dhakephalkar, P. K., Banpurkar, A. G., & Chopade, B. A. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.02.006 · Cited by 517
Research works printed but not linked: 5
- (1999). Monsoons to Microbes: Understanding the Ocean's Role in Human Health, The National Academies Press.
- Okami, 1993, The search for bioactive metabolites form marine bacteria, Mar. Biotechnol, 1, 59
- Falch, 1996, What remains of cyanobacteria?, Pharm. i. u. Zeit, 25, 311
- Fusetani, N (2000). Drugs from the Sea, Karger Publishers. · DOI
- Fusetani, N (2000). Drugs from the Sea, Karger Publishers. · DOI
Cited by
Sorted by citations
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,880
Martins, A., Vieira, H., Gaspar, H., & Santos, S. (2014) · Marine Drugs · doi:10.3390/md12021066 · Cited by 600
Marine Natural Products: A Source of Novel Anticancer Drugs
Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., et al. (2019) · Marine Drugs · doi:10.3390/md17090491 · Cited by 555
“Cyanobacteria produce a family of antitumor agents known as cryptophycins, which interfere with tubulin assembly [101].”
BackgroundBlunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2011) · Natural Product Reports · doi:10.1039/c2np00090c · Cited by 489
Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
Garcia‐Vilas, J. A., Martı́nez-Poveda, B., Quesada, A. R., & Medina, M. Á. (2015) · Marine Drugs · doi:10.3390/md14010001 · Cited by 296
Bioactive Peptides and Depsipeptides with Anticancer Potential: Sources from Marine Animals
Suárez-Jiménez, G. M., Burgos‐Hernández, A., & Ezquerra‐Brauer, J. M. (2012) · Marine Drugs · doi:10.3390/md10050963 · Cited by 276
Hu, Y., Chen, J., Hu, G., Yu, J., Zhu, X., Lin, Y., Chen, S., & Yuan, J. X. (2015) · Marine Drugs · doi:10.3390/md13010202 · Cited by 267
Falaise, C., François, C., Travers, M., Morga, B., Haure, J., Tremblay, R., Turcotte, F., Pasetto, P., Gastineau, R., Hardivillier, Y., et al. (2016) · Marine Drugs · doi:10.3390/md14090159 · Cited by 262
Caruso, G., Floris, R., Serangeli, C., & Paola, L. D. (2020) · Marine Drugs · doi:10.3390/md18120622 · Cited by 275
What is a Bioactive Compound? A Combined Definition for a Preliminary Consensus
Guaâdaoui, A., Benaicha, S., ELMAJDOUB, N., Bellaoui, M., & Hamal, A. (2014) · International Journal of Nutrition and Food Sciences · doi:10.11648/j.ijnfs.20140303.16 · Cited by 249
Bioactive Pigments from Marine Bacteria: Applications and Physiological Roles
Soliev, A. B., Hosokawa, K., & Enomoto, K. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2011/670349 · Cited by 229
Pharmaceutical applications of cyanobacteria—A review
Vijayakumar, S., & Menakha, M. (2015) · Journal of Acute Medicine · doi:10.1016/j.jacme.2015.02.004 · Cited by 205
Marine Microbial-Derived Molecules and Their Potential Use in Cosmeceutical and Cosmetic Products
Corinaldesi, C., Barone, G., Marcellini, F., Dell’Anno, A., & Danovaro, R. (2017) · Marine Drugs · doi:10.3390/md15040118 · Cited by 207
Ramanathan, S., Kannappan, A., Shi, C., & Lin, X. (2021) · Marine Drugs · doi:10.3390/md19100530 · Cited by 216
Exploring the Valuable Carotenoids for the Large-Scale Production by Marine Microorganisms
Torregrosa‐Crespo, J., Montero, Z., Fuentes, J. L., García-Galbis, M. R., Garbayo, I., Vílchez, C., & Martínez‐Espinosa, R. M. (2018) · Marine Drugs · doi:10.3390/md16060203 · Cited by 189
Biosurfactants Produced by Marine Microorganisms with Therapeutic Applications
Gudiña, E. J., Teixeira, J. A., & Rodrigues, L. R. (2016) · Marine Drugs · doi:10.3390/md14020038 · Cited by 179
Microorganisms living on macroalgae: diversity, interactions, and biotechnological applications
Martin, M., Portetelle, D., Michel, G., & Vandenbol, M. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5557-2 · Cited by 191
Marine-Derived Compounds with Potential Use as Cosmeceuticals and Nutricosmetics
Alves, A., Sousa, E., Kijjoa, A., & Pinto, M. (2020) · Molecules · doi:10.3390/molecules25112536 · Cited by 169
Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives
Tortorella, E., Tedesco, P., Esposito, F. P., January, G. G., Fani, R., Jaspars, M., & de Pascale, D. (2018) · Marine Drugs · doi:10.3390/md16100355 · Cited by 168
Biologically active secondary metabolites from Actinomycetes
Solecka, J., Ziemska, J., Postek, M., & Rajnisz, A. (2012) · Open Life Sciences · doi:10.2478/s11535-012-0036-1 · Cited by 162
Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi
Jin, L., Quan, C., Hou, X., & Fan, S. (2016) · Marine Drugs · doi:10.3390/md14040076 · Cited by 161
Mazard, S., Penesyan, A., Ostrowski, M. D., Paulsen, I. T., & Egan, S. (2016) · Marine Drugs · doi:10.3390/md14050097 · Cited by 170
Spiroindimicins A–D: New Bisindole Alkaloids from a Deep-Sea-Derived Actinomycete
Zhang, W., Liu, Z., Li, S., Yang, T., Zhang, Q., Ma, L., Tian, X., Zhang, H., Huang, C., Zhang, S., et al. (2012) · Organic Letters · doi:10.1021/ol301343n · Cited by 147
Sosa‐Hernández, J. E., Escobedo-Avellaneda, Z. J., Iqbal, H. M. N., & Welti‐Chanes, J. (2018) · Molecules · doi:10.3390/molecules23112953 · Cited by 134
Next Generation Sequencing of Actinobacteria for the Discovery of Novel Natural Products
Gomez‐Escribano, J. P., Alt, S., & Bibb, M. J. (2016) · Marine Drugs · doi:10.3390/md14040078 · Cited by 124
Antimicrobial Peptides from Marine Proteobacteria
Desriac, F., Jégou, C., Balnois, E., Brillet, B., Chevalier, P. L., & Fleury, Y. (2013) · Marine Drugs · doi:10.3390/md11103632 · Cited by 119
An Overview on Marine Sponge-Symbiotic Bacteria as Unexhausted Sources for Natural Product Discovery
Brinkmann, C., Marker, A., & Kurtböke, D. İ. (2017) · Diversity · doi:10.3390/d9040040 · Cited by 121
Initial and Bulk Extraction of Natural Products Isolation
Seidel, V. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-624-1_2 · Cited by 121
Ecological and Industrial Implications of Dynamic Seaweed-Associated Microbiota Interactions
Menaa, F., Wijesinghe, P. A. U. I., Thiripuranathar, G., Uzair, B., Iqbal, H., Khan, B. A., & Menaa, B. (2020) · Marine Drugs · doi:10.3390/md18120641 · Cited by 119
Cyanobacteria: potential candidates for drug discovery
Dixit, R. B., & Suseela, M. R. (2013) · Antonie van Leeuwenhoek · doi:10.1007/s10482-013-9898-0 · Cited by 120
pH-responsive Capsaicin@chitosan nanocapsules for antibiofouling in marine applications
Wang, W., Hao, X., Chen, S., Yang, Z., Wang, C., Yan, R., Zhang, X., Liu, H., Shao, Q., & Guo, Z. (2018) · Polymer · doi:10.1016/j.polymer.2018.10.067 · Cited by 110
The cave microbiome as a source for drug discovery: Reality or pipe dream?
Ghosh, S. B., Kuisienė, N., & Cheeptham, N. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.018 · Cited by 108
Zhang, Y., Li, X.-G., Bartlett, D. H., & Xiao, X. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.02.013 · Cited by 103
Balan, S. S., Kumar, C. G., & Jayalakshmi, S. (2016) · Microbiological Research · doi:10.1016/j.micres.2016.10.005 · Cited by 98
Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides
Kang, H. K., Choi, M., Seo, C., & Park, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030919 · Cited by 98
Epidemiology and management of brown rot on stone fruit caused by Monilinia laxa
Rungjindamai, N., Jeffries, P., & Xu, X. (2014) · European Journal of Plant Pathology · doi:10.1007/s10658-014-0452-3 · Cited by 96
Actinobacteria Isolated From Laminaria ochroleuca: A Source of New Bioactive Compounds
Girão, M., Ribeiro, I., Ribeiro, T., Azevedo, I. C., Pereira, F., Urbatzka, R., Leão, P. N., & Carvalho, M. F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00683 · Cited by 98
Montaser, R., Paul, V. J., & Luesch, H. (2011) · Phytochemistry · doi:10.1016/j.phytochem.2011.07.014 · Cited by 91
Antioxidant Molecules from Marine Fungi: Methodologies and Perspectives
Vitale, G. A., Coppola, D., Esposito, F. P., Buonocore, C., Ausuri, J., Tortorella, E., & de Pascale, D. (2020) · Antioxidants · doi:10.3390/antiox9121183 · Cited by 89
Progress in Research on Bioactive Secondary Metabolites from Deep-Sea Derived Microorganisms
Wang, Y., Meng, L., & Wang, B. (2020) · Marine Drugs · doi:10.3390/md18120614 · Cited by 86
Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies
Ribeiro, R., Pinto, E., Fernandes, C., & Sousa, E. (2022) · Marine Drugs · doi:10.3390/md20060397 · Cited by 88
Rocha-Martin, J., Harrington, C., Dobson, A., & O'Gara, F. (2014) · Marine Drugs · doi:10.3390/md12063516 · Cited by 84
Christie‐Oleza, J. A., Piña‐Villalonga, J. M., Bosch, R., Nogales, B., & Armengaud, J. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013110 · Cited by 88
Major Commercial Products from Micro- and Macroalgae
Griffiths, M. J., Harrison, S. T. L., Smit, M., & Maharajh, D. (2016) · Green energy and technology · doi:10.1007/978-3-319-12334-9_14 · Cited by 86
Exopolysaccharides from Marine Microbes: Source, Structure and Application
Qi, M., Zheng, C., Wu, W., Yu, G., & Wang, P. (2022) · Marine Drugs · doi:10.3390/md20080512 · Cited by 83
Chai, Y.-J., Cui, C., Li, C.-W., Wu, C., Tian, C.-K., & Hua, W. (2012) · Marine Drugs · doi:10.3390/md10030559 · Cited by 78
Fungal Endosymbionts of Seaweeds
Suryanarayanan, T. S. (2011) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-23342-5_3 · Cited by 76
Antiproliferative Activity of Cyanophora paradoxa Pigments in Melanoma, Breast and Lung Cancer Cells
Baudelet, P.-H., Gagez, A.-L., Bérard, J., Juin, C., Bridiau, N., Kaas, R., Thiéry, V., Cadoret, J., & Picot, L. (2013) · Marine Drugs · doi:10.3390/md11114390 · Cited by 74
Nine New and Five Known Polyketides Derived from a Deep Sea-Sourced Aspergillus sp. 16-02-1
Chen, X.-W., Li, C., Cui, C., Hua, W., Zhu, T., & Gu, Q. (2014) · Marine Drugs · doi:10.3390/md12063116 · Cited by 75
Biotechnological Potential of Sponge-Associated Bacteria
Santos-Gandelman, J. F., Giambiagi-deMarval, M., Oelemann, W. M. R., & Laport, M. S. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140711115033 · Cited by 70
Ko, W., Sohn, J. H., Jang, J., Ahn, J. S., Kang, D. G., Lee, H. S., Kim, J.-S., Kim, Y., & Oh, H. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.024 · Cited by 69
Algal bioactive compounds in the cosmeceutical industry: a review
Jahan, A., Ahmad, I. Z., Fatima, N., Ansari, V. A., & Akhtar, J. (2017) · Phycologia · doi:10.2216/15.58.1 · Cited by 68
Damare, S. R., Singh, P., & Raghukumar, S. (2011) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-23342-5_14 · Cited by 67
Alghazeer, R. O., Whida, F., Abduelrhman, E., Gammoudi, F., & Azwai, S. M. (2013) · Natural Science · doi:10.4236/ns.2013.51002 · Cited by 70
Analytical techniques for discovery of bioactive compounds from marine fungi
Duarte, K. R., Rocha‐Santos, T., Freitas, A. C., & Duarte, A. C. (2012) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2011.10.014 · Cited by 69
Antibiotic research in the age of omics: from expression profiles to interspecies communication
Wecke, T., & Mascher, T. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr373 · Cited by 62
Anticancer potential of natural peptides from terrestrial and marine environments: A review
Eghtedari, M., Porzani, S. J., & Nowruzi, B. (2021) · Phytochemistry Letters · doi:10.1016/j.phytol.2021.02.008 · Cited by 62
Emerging biopharmaceuticals from bioactive peptides derived from marine organisms
Anjum, K., Abbas, S. Q., Akhter, N., Shagufta, B. I., Shah, S. A. A., & Hassan, S. S. U. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12925 · Cited by 63
Yamazaki, H., Rotinsulu, H., Narita, R., Takahashi, R., & Namikoshi, M. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00669 · Cited by 62
Bilal, M., & Iqbal, H. M. N. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.037 · Cited by 62
Bibi, F., Yasir, M., Al-Sofyani, A., Naseer, M. I., & Azhar, E. I. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.02.002 · Cited by 59
Symbiotic Microbes from Marine Invertebrates: Driving a New Era of Natural Product Drug Discovery
Blockley, A., Elliott, D. R., Roberts, A. P., & Sweet, M. J. (2017) · Diversity · doi:10.3390/d9040049 · Cited by 58
Helber, S. B., Hoeijmakers, D. J. J., Muhando, C. A., Rohde, S., & Schupp, P. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197617 · Cited by 56
Torres, M., Dessaux, Y., & Llamas, I. (2019) · Marine Drugs · doi:10.3390/md17030191 · Cited by 56
Lloyd, M. M., & Pespeni, M. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-34697-w · Cited by 54
Neomaclafungins A–I: Oligomycin-Class Macrolides from a Marine-Derived Actinomycete
Sato, S., Iwata, F., Yamada, S., & Katayama, M. (2012) · Journal of Natural Products · doi:10.1021/np300719g · Cited by 53
New Polyaromatic Metabolites from a Marine-Derived Fungus Penicillium sp.
Julianti, E., Lee, J., Liao, L., Park, W., Park, S., Oh, D., Oh, K., & Shin, J. (2013) · Organic Letters · doi:10.1021/ol4002174 · Cited by 53
Putra, N. R., Fajriah, S., Qomariyah, L., Dewi, A. S., Rizkiyah, D. N., Irianto, I., Rusmin, D., Melati, M., Trisnawati, W., Darwati, I., et al. (2023) · South African Journal of Chemical Engineering · doi:10.1016/j.sajce.2023.11.017 · Cited by 65
Venkatachalam, M., Gérard, L., Milhau, C., Vinale, F., Dufossé, L., & Fouillaud, M. (2019) · Microorganisms · doi:10.3390/microorganisms7010010 · Cited by 52
Discovery, Development, and Regulation of Natural Products
Krause, J., & Tobi, G. (2013) · InTech eBooks · doi:10.5772/56424 · Cited by 56
Bioactive Secondary Metabolites from Marine Microbes for Drug Discovery
Nikapitiya, C. (2012) · Advances in food and nutrition research · doi:10.1016/b978-0-12-416003-3.00024-x · Cited by 51
Odeleye, T., White, W. L., & Lu, J. (2019) · Food & Function · doi:10.1039/c9fo00172g · Cited by 53
Alkaloidal Metabolites from a Marine-Derived Aspergillus sp. Fungus
Liao, L., You, M., Chung, B., Oh, D., Oh, K., & Shin, J. (2015) · Journal of Natural Products · doi:10.1021/np500683u · Cited by 50
Ray, B., Schütz, M., Mukherjee, S., Jana, S., Ray, S., & Marschall, M. (2020) · Polymers · doi:10.3390/polym13010136 · Cited by 50
Acremostrictin, a Highly Oxygenated Metabolite from the Marine Fungus Acremonium strictum
Julianti, E., Oh, H., Jang, K. H., Lee, J. K., Lee, S. K., Oh, D., Oh, K., & Shin, J. (2011) · Journal of Natural Products · doi:10.1021/np200707y · Cited by 49
Pederson, P. J., Mfuh, A. M., Arman, H. D., Shaffer, C. V., Larionov, O. V., & Mooberry, S. L. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00963 · Cited by 48
Matobole, R., van Zyl, L. J., Parker‐Nance, S., Davies‐Coleman, M. T., & Trindade, M. (2017) · Marine Drugs · doi:10.3390/md15020047 · Cited by 48
Dong, Y., Cui, C., Li, C., Hua, W., Wu, C., Zhu, T., & Gu, Q. (2014) · Marine Drugs · doi:10.3390/md12084326 · Cited by 49
Girija, A. S. S., Duraipandiyan, V., Pandi, S., Gajendran, H., & Rajagopal, R. (2014) · International Scholarly Research Notices · doi:10.1155/2014/820745 · Cited by 47
Microcystin-LR and Cylindrospermopsin Induced Alterations in Chromatin Organization of Plant Cells
Máthé, C., M‐Hamvas, M., & Vasas, G. (2013) · Marine Drugs · doi:10.3390/md11103689 · Cited by 46
Li, D., Han, T., Guan, L., Bai, J., Zhao, N., Li, Z., Wu, X. T., & Hua, H. (2015) · Natural Product Research · doi:10.1080/14786419.2015.1043553 · Cited by 45
Ritchie, K. B., Schwarz, M. T., Mueller, J., Lapacek, V. A., Merselis, D. G., Walsh, C. J., & Luer, C. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01050 · Cited by 45
Harnessing microalgae as sustainable cellular factories for biopharmaceutical production
Goshtasbi, H., Okolodkov, Y. B., Movafeghi, A., Awale, S., Safary, A., Barar, J., & Omidi, Y. (2023) · Algal Research · doi:10.1016/j.algal.2023.103237 · Cited by 47
Antibacterial products of marine organisms
Ng, T. B., Cheung, R. C. F., Wong, J. H., Bekhit, A. A., & Bekhit, A. E. A. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6553-x · Cited by 44
Tellurite-dependent blackening of bacteria emerges from the dark ages
Presentato, A., Turner, R. J., Vásquez, C. C., Yurkov, V., & Zannoni, D. (2019) · Environmental Chemistry · doi:10.1071/en18238 · Cited by 46
Zhang, L., Li, B., Qin, Y., Karthik, L., Zhu, G., Hou, C., Jiang, L., Liu, M., Ye, X., Liu, M., et al. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10217-2 · Cited by 42
Anticancer compounds from cyanobacterium Lyngbya species: a review
Swain, S. S., Padhy, R. N., & Singh, P. K. (2015) · Antonie van Leeuwenhoek · doi:10.1007/s10482-015-0487-2 · Cited by 44
Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes the Akt pathway
García‐Caballero, M., Marí‐Beffa, M., Cañedo, L. M., Medina, M. Á., & Quesada, A. R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.007 · Cited by 42
Lumazine Peptides from the Marine-Derived Fungus Aspergillus terreus
You, M., Liao, L., Hong, S. J., Park, W., Kwon, D. I., Lee, J., Noh, M., Oh, D., Oh, K., & Shin, J. (2015) · Marine Drugs · doi:10.3390/md13031290 · Cited by 42
Priya, A. M., & Jayachandran, S. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.11.005 · Cited by 41
Promises of natural products as clinical applications for cancer
Deng, R., Zong, G., Wang, X., Yue, B.-J., Cheng, P., Tao, R., Li, X., Wei, Z., & Lu, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189241 · Cited by 45
Al-Amoudi, S., Essack, M., Simões, M. F., Bougouffa, S., Soloviev, I. D., Archer, J. A. C., Lafi, F. F., & Bajić, V. B. (2016) · Marine Drugs · doi:10.3390/md14090165 · Cited by 40
Diversity and antimicrobial potential in sea anemone and holothurian microbiomes
León‐Palmero, E., Joglar, V., Álvarez, P. A., Martín-Platero, A. M., Llamas, I., & Reche, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196178 · Cited by 41
Acremolin, a new 1H-azirine metabolite from the marine-derived fungus Acremonium strictum
Julianti, E., Oh, H., Lee, H., Oh, D., Oh, K., & Shin, J. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.03.133 · Cited by 40
Marine-Derived Compounds and Prospects for Their Antifungal Application
Cardoso, J., Nakayama, D. G., Sousa, E., & Pinto, E. (2020) · Molecules · doi:10.3390/molecules25245856 · Cited by 41
Reina, J. C., Pérez‐Victoria, I., Martı́n, J., & Llamas, I. (2019) · Marine Drugs · doi:10.3390/md17090494 · Cited by 45
Zhen, X., Gong, T., Liu, F., Zhang, P., Zhou, W.-Q., Li, Y., & Zhu, P. (2015) · Marine Drugs · doi:10.3390/md13116947 · Cited by 37
Donato, P. D., Poli, A., Taurisano, V., Abbamondi, G. R., Nicolaus, B., & Tommonaro, G. (2016) · Journal of Marine Science and Engineering · doi:10.3390/jmse4020034 · Cited by 39
Wu, C., Yi, L., Cui, C., Li, C., Wang, N., & Han, X. Q. (2015) · Marine Drugs · doi:10.3390/md13042465 · Cited by 37
Bu, Y.-Y., Yamazaki, H., Takahashi, O., Kirikoshi, R., Ukai, K., & Namikoshi, M. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.82 · Cited by 36
Metadata
- Authors
- Bhatnagar, I., & Kim, S.-K.
- Affiliations
- Pukyong National University (KR)
- Corresponding author
- Kim, Se-Kwon
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2010-10-15
- Volume
- 8
- Issue
- 10
- Pages
- 2673-2701
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC2993000
- OpenAlex
- W2029997716
- Cited by
- 384
- References
- 124
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 21 · 2023: 23 · 2022: 28 · 2021: 18 · 2020: 39 · 2019: 26 · 2018: 25 · 2017: 26 · 2016: 32 · 2015: 28 · 2014: 30 · 2013: 23 · 2012: 27
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Keywords
- marine microorganisms, bioactive secondary metabolites, marine natural products, antibacterial agents, antifungal agents, anticancer agents, marine bacteria, actinomycetes, cyanobacteria, diatoms, microbial symbionts, drug discovery screening, cosmeceuticals, nutraceuticals
- MeSH terms
- Cyanobacteria, Animals, Anti-Bacterial Agents, Antifungal Agents, Antineoplastic Agents, Bacteria, Clinical Trials as Topic, Fungi, Seawater, Symbiosis, Diatoms, Drug Discovery, Microalgae, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
